Biotechnology Scilex Holding Company Sets Launch Price Of $595 Per 150ml Bottle Of Gloperba®, Its First And Only Liquid Oral Version Of The Anti-Gout Medicine Colchicine Indicated For The Prophylaxis Of Painful Gout Flares In Adults; Expected Plans To Launch In The First Half Of 2024 – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Scilex Holding Company Announces Major Initiative With A Leading National Pharmacy Chain To Stock GLOPERBA® In Most Of Their Stores Throughout the U.S. – Scilex Holding (NASDAQ:SCLX) Read more